<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38960664</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-6256</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>American journal of epidemiology</Title><ISOAbbreviation>Am J Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Temporal changes in the risk of six-month post-covid symptoms: a national population-based cohort study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">kwae174</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/aje/kwae174</ELocationID><Abstract><AbstractText>It is unclear how the risk of post-covid symptoms evolved during the pandemic, especially before the spread of Severe Acute Respiratory Syndrome Coronavirus 2 variants and the availability of vaccines. We used modified Poisson regressions to compare the risk of six-month post-covid symptoms and their associated risk factors according to the period of first acute covid: during the French first (March-May 2020) or second (September-November 2020) wave. Non-response weights and multiple imputation were used to handle missing data. Among participants aged 15 or more in a national population-based cohort, the risk of post-covid symptoms was 14.6% (95% CI: 13.9%, 15.3%) in March-May 2020, versus 7.0% (95% CI: 6.3%, 7.7%) in September-November 2020 (adjusted RR: 1.36, 95% CI: 1.20, 1.55). For both periods, the risk was higher in the presence of baseline physical condition(s), and it increased with the number of acute symptoms. During the first wave, the risk was also higher for women, in the presence of baseline mental condition(s), and it varied with educational level. In France in 2020, the risk of six-month post-covid symptoms was higher during the first than the second wave. This difference was observed before the spread of variants and the availability of vaccines.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2024. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pastorello</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyer</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Public Health Department, Assistance Publique-H&#xf4;pitaux de Paris Universit&#xe9; Paris-Saclay, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coste</LastName><ForeName>Jo&#xeb;l</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>French Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davisse-Paturet</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lamballerie</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Emerging Viruses Unit, Aix-Marseille University, French National Research Institute for Sustainable Development 190 - National Institute of Health and Medical Research 1207, University Hospital Institute M&#xe9;diterran&#xe9;e Infection, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melchior</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pierre Louis Institute of Epidemiology and Public Health, Sorbonne University, National Institute of Health and Medical Research, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novelli</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahib</LastName><ForeName>Delphine</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>French Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bajos</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Interdisciplinary Institute of Social Issues - social sciences, politics, health, French National Center for Scientific Research, School for Advanced Studies in Social Sciences, National Institute of Health and Medical Research, Aubervilliers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuillermoz</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franck</LastName><ForeName>Jeanna-Eve</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Interdisciplinary Institute of Social Issues - social sciences, politics, health, French National Center for Scientific Research, School for Advanced Studies in Social Sciences, National Institute of Health and Medical Research, Aubervilliers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manto</LastName><ForeName>Carmelite</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouquette</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Public Health Department, Assistance Publique-H&#xf4;pitaux de Paris Universit&#xe9; Paris-Saclay, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warszawski</LastName><ForeName>Josiane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Paris-Saclay University, University of Versailles Saint-Quentin-en-Yvelines, National Institute of Health and Medical Research, Center for Epidemiology and Population Health, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiology and Public Health Department, Assistance Publique-H&#xf4;pitaux de Paris Universit&#xe9; Paris-Saclay, Le Kremlin-Bic&#xea;tre, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>EpiCov Study Group</LastName><ForeName>For The</ForeName><Initials>FT</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Epidemiol</MedlineTA><NlmUniqueID>7910653</NlmUniqueID><ISSNLinking>0002-9262</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-Cov-2</Keyword><Keyword MajorTopicYN="N">cohort</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">multiple imputation</Keyword><Keyword MajorTopicYN="N">population based</Keyword><Keyword MajorTopicYN="N">post-covid symptoms</Keyword><Keyword MajorTopicYN="N">survey weights</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>4</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>3</Day><Hour>21</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38960664</ArticleId><ArticleId IdType="doi">10.1093/aje/kwae174</ArticleId><ArticleId IdType="pii">7705577</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>